《Table 2Clinical outcomes of enrolled patients.》

《Table 2Clinical outcomes of enrolled patients.》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Self-expandable metal stents for choledocholithiasis in Billroth II gastrectomy patients》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
No.:number；F:female；M:male；ML:mechanical lithotripsy.

During the study period，143 ERCP procedures were conducted in 80 patients（58 males，mean age 75.6 years）with a history of Billroth II gastrectomy.Among them，15 patients（18.8%）underwent temporary FCSEMS placement for the management of CBD stones.Clinical characteristics and outcomes of the patients are summarized in Tables 1 and 2.Ampullary intervention with FC-SEMSs was technically successful in all 15 patients.AOV dilation followed by immediate reconstruction of a robust conduit with FC-SEMSs，facilitated removal of CBD stones completely in a single session from all patients.The median age of the 15 patients was78 years（range，47–85），the median diameter of CBD was 13 mm（range，10–22），and the median diameter of CBD stones was 9 mm（range，5–30）.

图表编号XD0020458100    严禁用于非法目的
绘制时间2018.12.15
作者Min-Gui Han、Eunae Cho、Chang-Hwan Park、Chung-Hwan Jun、Seon-Young Park
绘制单位Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Hospital、Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Hospital、Division of Gastroenterology, Department of Internal Me
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 2Clinical outcomes in the intention-to-treat population.》2020.10.01
  2. 《Table 9 Outcome of laparoscopic-assisted endoscopic retrograde cholangiopancreatography in patients undergoing Roux-en-Y》2019.07.14
  3. 《Table 3The second infusion of CAR T cells and patient outcomes.》2019.02.01
  4. 《Table 2The first infusion of CAR T cells and patient outcomes.》2019.02.01
  5. 《Table 2 Peer-reviewed literature reports on the clinical outcomes of patients undergoing endoscopic transluminal necrose》2019.04.27
  6. 《Table 2 Peer-reviewed literature reports on the clinical outcomes of patients undergoing endoscopic transluminal necrose》2019.04.27
  7. 《Table 1 Peer-reviewed literature reports on the clinical outcomes of patients undergoing percutaneous catheter drainage》2019.04.27
  8. 《Table 5.Secondary Treatment Outcomes of RUTI Patients[Case (%) ]》2019.01.01
  9. 《Table 4.Primary Treatment Outcomes of RUTI Patients[Case (%) ]》2019.01.01
  10. 《Table 1 Detailed characteristics of the 165 enrolled patients and submucosal tumors n (%)》2019.01.14
  11. 《Table 2 The characteristics of patients at enrollment》2019.01.07
  12. 《Table 2.Treatment, outcome and survival time of 13 induction-therapeutic patients》2019.02.20
  13. 《Table 5 Comparison of surgical outcomes between patients with absent and present SNAP》2019.03.01
  14. 《Table 1 Baseline parameters and pregnancy outcomes of patients in n-FSH and h-FSH groupsa)》2019.01.05
  15. 《Table 1Baseline characteristics and procedural outcomes of patients who underwent EUS-TD for PCs due to AP.》2019.02.15
  16. 《Table 3 Surgical outcomes of patients with infantile esotropia who underwent bilateral medial rectus muscle recession be》2018.12.18
  17. 《Table 1Baseline characteristics of enrolled patients.》2018.12.15
  18. 《Table 2Clinical characteristics of patients with HBV-related hepatocellular carci-noma and expression levels of IL-37b.》2018.10.15
  19. 《Table 2Surgical outcomes of patients who underwent ABO-I LDLT.》2018.04.01
  20. 《Table 3Postoperative outcomes of the study patients.》2018.02.01

随机翻阅

《表3 2016～2018年12种抗生素对大肠埃希菌的抗菌活性》 《表2 两组病灶体积、痛经评分和血红蛋白浓度比较（±s)》 《表2 两组治疗前后证候积分比较（分，±s)》 《表2 0.5%藜芦碱可溶液剂防治枣树红蜘蛛试验结果》 《表2 两组的预后效果对比例（%）》 《表1 HARUS数据集当中的活动转换逻辑》 《表1 每个子区间内高被引作者统计》 《表4 玉溪市各县区海拔及2007―2017年平均日照时间》 《表1：实验组和对照组在实验前元认知策略使用情况》 《表2 各数据集目标数与维数》